Basic Information | Post buying leads | Suppliers | Cas Database |
Molecular Formula: C11H18N2O3
Molar mass: 226.27 g/mol
EINECS: 200-330-7
Density: 1.069 g/cm3
Index of Refraction: 1.46
Melting point: 156-158°C
Water solubility: <0.1 g/100 mL at 18.5 ºC
Appearance: Crystalline Solid
Stable: Stable. Incompatible with strong oxidizing agents. Hygroscopic
Product categories of Amytal (57-43-2): Miscellaneous;Intermediates & Fine Chemicals;Pharmaceuticals;Isotope Labeled Compounds
Structure of Amytal (57-43-2):
XLogP3-AA: 2.1
H-Bond Donor: 2
H-Bond Acceptor: 3
Systematic Name: 5-Ethyl-5-isopentyl-hexahydropyrimidine-2,4,6-trione
SMILES: O=C1NC(=O)NC(=O)C1(CCC(C)C)CC
InChI: InChI=1/C11H18N2O3/c1-4-11(6-5-7(2)3)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)
InChIKey: VIROVYVQCGLCII-UHFFFAOYAO
Std. InChI: InChI=1S/C11H18N2O3/c1-4-11(6-5-7(2)3)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)
Std. InChIKey: VIROVYVQCGLCII-UHFFFAOYSA-N
Amytal (57-43-2) can be used for controlled substance (depressant) for sedative and hypnotic.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
cat | LDLo | oral | 100mg/kg (100mg/kg) | Physiological Reviews. Vol. 19, Pg. 472, 1939. | |
dog | LD50 | intravenous | 58mg/kg (58mg/kg) | Drugs in Japan Vol. -, Pg. 63, 1990. | |
dog | LDLo | oral | 250mg/kg (250mg/kg) | BEHAVIORAL: SLEEP | Journal of Pharmacology and Experimental Therapeutics. Vol. 26, Pg. 371, 1926. |
mammal (species unspecified) | LDLo | oral | 550mg/kg (550mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 42, Pg. 253, 1931. | |
mouse | LD50 | intraperitoneal | 175mg/kg (175mg/kg) | BEHAVIORAL: GENERAL ANESTHETIC | Journal of Medicinal Chemistry. Vol. 10, Pg. 1078, 1967. |
mouse | LD50 | oral | 345mg/kg (345mg/kg) | Journal of the American Chemical Society. Vol. 61, Pg. 96, 1939. | |
mouse | LD50 | subcutaneous | 212mg/kg (212mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 688, 1965. | |
rabbit | LD50 | intravenous | 49mg/kg (49mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 96, Pg. 209, 1949. | |
rabbit | LD50 | oral | 575mg/kg (575mg/kg) | Drugs in Japan Vol. -, Pg. 63, 1990. | |
rabbit | LDLo | intraperitoneal | 90mg/kg (90mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 41, Pg. 465, 1931. | |
rabbit | LDLo | subcutaneous | 170mg/kg (170mg/kg) | Journal of the American Chemical Society. Vol. 45, Pg. 243, 1923. | |
rat | LD50 | intraperitoneal | 115mg/kg (115mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | |
rat | LD50 | oral | 250mg/kg (250mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Arzneimittel-Forschung. Drug Research. Vol. 21, Pg. 719, 1971. |
rat | LD50 | subcutaneous | 190mg/kg (190mg/kg) | Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 152, Pg. 341, 1930. |
A poison by ingestion, intravenous, intraperitoneal, and subcutaneous routes. See also BARBITURATES. When heated to decomposition it emits toxic fumes of NOx.
Amytal (57-43-2) is a drug that is a barbiturate derivative, and also can be called Amylobarbitone ; Amobarbital ; 2,4,6(1H,3H,5H)-pyrimidinetrione, 5-ethyl-5-(3-methylbutyl)- ;and 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione .Amines may be incompatible with halogenated organics, isocyanates, peroxides, anhydrides, phenols (acidic), epoxides, and acid halides.Amines are chemical bases.They neutralize acids to form salts plus water.